Cerebain Biotech (CBBT) Rockets 350% YTD Amid Biotech Bubble

There have been many stocks that have generated considerable gains so far this year and one of the notable ones is that of Cerebain Biotech Corp (OTC: CBBT).

Cerebain Biotech (CBBT) Rockets 350% YTD Amid Biotech Bubble

Since the start of 2021, the stock has rallied by as much as 350% and has emerged as one of the major gainers. While there have been no recent developments, it might be worthwhile for investors to take a look at development from back in November 2020.

Back on November 25, 2020, the company announced that it roped in PKG Inc to become the main manufacturer for Xometry and Clear Mask LLC. It goes without saying that it was a significant development for Cerebrain and the rally in the stock this year is understandable. Clear Mask is a wholly transparent surgical mask and more importantly, it is the only such mask to have been cleared by the United States Food and Drug Administration.

Richard McEntire

Finance and Entertainment ReporterRichard is a bottle of wine - the older the sweeter. He has already found the sweetest hobby in writing entertainment and finance news for Own Snap. Readers get the updated posts regularly from him searching for real-time news.